This analysis incorporates WHO global hepatitis B vaccination goals, but not screening or antiviral treatment goals of >90% of people with chronic hepatitis B diagnosed and >80% of people diagnosed are treated. This evidence concerns the gene PPIB and chronic hepatitis B virus infection.